SAN FRANCISCO , April 18, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Hydrogels - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.
FACTS AT A GLANCE What's New for 2022?
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year
Edition: 8; Released: February 2022 Executive Pool: 13911 Companies: 59 - Players covered include 3M Company; Alliqua BioMedical, Inc.; Ashland, Inc.; B. Braun Melsungen AG; BSN Medical GmbH; Cardinal Health, Inc.; Coloplast A/S; ConvaTec, Inc.; Cosmo Bio Co., Ltd.; Derma Sciences, Inc.; Evonik Industries AG; Gentell Corporation; Hollister, Inc.; Johnson & Johnson; Medline Industries, Inc.; Medtronic PLC; Molnlycke Health Care; Momentive Performance Materials, Inc.; MPM Medical LLC; Ocular Therapeutix, Inc.; Paul Hartmann AG; Procyon Corporation; Royal DSM NV; Smith & Nephew PLC and Others. Coverage: All major geographies and key segments Segments: Raw Material (Natural, Synthetic, and Hybrid); Composition (Polyacrylate, Polyacrylamide, Silicon, and Other Compositions); and Application (Agriculture, Healthcare & Hygiene, Contact Lenses, Drug Delivery, Tissue Engineering, and Other Applications) Geographies: World; United States ; Canada ; Japan ; China ; Europe (France ; Germany ; Italy ; United Kingdom ; Spain ; Russia ; and Rest of Europe ); Asia-Pacific (Australia ; India ; South Korea ; and Rest of Asia-Pacific ); Latin America (Argentina ; Brazil ; Mexico ; and Rest of Latin America ); Middle East (Iran ; Israel ; Saudi Arabia ; United Arab Emirates ; and Rest of Middle East ); and Africa .
Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry
Global Hydrogels Market to Reach $16 Billion by 2026
Hydrogels are flexible materials predominantly made of water and mixed with compounds to form three-dimensional solid polymeric materials. The water-insoluble polymer is essentially a gel-like or colloidal substance that is capable of absorbing and retaining high water content of around 90% within its structure. Sodium polyacrylate, acrylate polymers, polyvinyl alcohol, and other co-polymers are the common ingredients present in hydrogel. Their specific structures, flexibility, and compatibility with different conditions of use facilitate their application in many fields and various processes ranging from medical to biological to industrial. Hydrogel can be found in many everyday products ranging from disposable nappies to plant-water crystals and soft contact lenses. Other application areas include scaffolds in tissue engineering, agriculture, dyes and heavy metal ions removal, and injectable hydrogel for spinal cord regeneration among others. New generation of hydrogels feature multi-layered and complex internal structures with controllable physical properties
Amid the COVID-19 crisis, the global market for Hydrogel estimated at US$13.3 Billion in the year 2022, is projected to reach a revised size of US$16 Billion by 2026, registering a compounded annual growth rate (CAGR) of 4.7% over the analysis period. Europe represents the largest regional market for Hydrogel, and is projected to reach US$4 Billion by 2026. China is expected to spearhead growth and emerge as the fastest growing regional market with a CAGR of 6.7% over the analysis period. Expanding application scope, rising demand for synthetic hydrogel, benefits over conventional substitutes, increasing demand in emerging economies, and growing R&D activities are the key drivers fuelling growth in the hydrogel market. Growing hygiene awareness, expanding infant and aging population in developing countries, and rising demand for feminine hygiene products is expected to augment consumption of hydrogel in hygiene sector. The high manufacturing cost of hydrogel and possibility of environmental issues faced in disposal of synthetic hydrogel are expected to restrain growth in the market.
Wound care is an emerging application area for hydrogel dressings as they accelerate the speed and success of wound healing. Hydrogel is added to traditional gauze or mesh materials to form hydrogel wound dressing. Hydrogel ensures that the wound bed remains moist enough, which prevents pain during dressing changes and promotes proper healing. They are increasingly used in treatment of necrotic wounds, dry wounds such as burns and radiation damage, partial or thick wounds, and autolytic debridement. Researchers continue to investigate new methods to use hydrogel for better wound care. Synthetic hydrogel is increasingly used in biomedical applications such as ophthalmology. Agriculture applications comprise a fast growing avenue for hydrogels, mainly driven by its ability to prevent soil erosion and hold moisture in arid areas, which enhances crop yield. Market for synthetic hydrogels is growing on the back of increasing demand in core applications including health care and hygiene, drug delivery systems, biotechnology processes and agriculture applications. Synthetic hydrogels made from different types of polymers including Biodegradable (such as synthetic peptides, degradable PEG, PPF-PEG, PHEMA-PCL), Non-Biodegradable (PVA, Pluronic® PEGDA, PNIPAm, PHEMA, PHPMA), and Bioactive (Growth factor-bearing, Enzyme-sensitive, Cell-adhesive) are experiencing growing use across various end-use verticals. Use of synthetic polymers is especially gaining traction in the manufacture of hydrogel tissue-engineered skeletons, as these polymers can be molecularly modified by mechanical strength, molecular weights, biodegradability and block structures. In the coming years, biodegradable and bioactive versions are expected to steer overall momentum in the overall synthetic hydrogels market, amid intensified demand for environmentally-sustainable products across end-use scenarios.
North America holds a dominant share of hydrogel market while Asia-Pacific is expected to witness high rate of growth during the analysis period. The large consumption of hydrogel in biotechnology and medicine, tissue engineering, contact lenses, and agriculture is expected to spur growth in the US, and Europe . The growing pharmaceuticals and healthcare, personal care and hygiene, and agriculture sectors in China , Japan , and India drive usage of hydrogel in the Asia-Pacific region. Other key factors such as strong economic growth, rapidly growing population, and rising per capita income are also expected to influence growth in the region. The rising consumption of baby products, oral care, skin care, and cosmetics is expected to spur robust growth in healthcare, beauty, and personal care sectors. The increasing demand for synthetic hydrogel is expected to be propelled by agriculture and growing demand for drug delivery systems. China is forecast to lead hydrogel consumption in the region, driven by burgeoning demand for cosmetics and expanding presence of both domestic and international cosmetic companies. In India , demand for hydrogel is mainly driven by the personal care sector. Rising consumer demand for products with natural ingredients and product innovations are anticipated to augment growth. The burgeoning consumption of hydrogel in tissue engineering, contact lenses, and biotechnology and medicine is expected to further propel demand for hydrogels. More
MarketGlass™ Platform Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.
Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android
About Global Industry Analysts, Inc. & StrategyR™ Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.
CONTACTS: Zak Ali Director, Corporate Communications Global Industry Analysts, Inc. Phone: 1-408-528-9966 www.StrategyR.com Email: ZA@StrategyR.com
LINKS Join Our Expert Panel https://www.strategyr.com/Panelist.asp
Connect With Us on LinkedIn https://www.linkedin.com/company/global-industry-analysts-inc./
Follow Us on Twitter https://twitter.com/marketbytes
Journalists & Media Info411@strategyr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/global-hydrogels-market-to-reach-16-billion-by-2026-301526441.html
SOURCE Global Industry Analysts, Inc.
It's important to remember that as we watch the stock market crash and our personal net worth take a big hit. While that has certainly happened, it's important to note that the stock market isn't the economy.
Economist Larry Summers was right about inflation last year — so we asked him what he sees coming next for the U.S. economy.
The first half of 2022 has been rocky. But Goldman likes this group to bounce back.
Over the past month, the odds of a home price correction spiked. That's according to an analysis CoreLogic ran for Fortune this week.
Your retirement savings are $1 million. You want $100,000 of yearly retirement income, including Social Security. Is that doable without tons of risk?
When legends speak, people listen – and few investors match the legendary status of Ray Dalio. The founder of Bridgewater Associates has built his firm from a 2-room apartment operation into the world’s largest hedge fund, with more than $150 billion in assets under management, and a net gain exceeding $46 billion. Dalio believes that the next two to four years will see our global economic and political systems change in ways that are unpredictable now. And the key to survival, for investors, ma
Shares of Tesla (NASDAQ: TSLA) sank on Friday, declining as much as 10.8% at one point during the trading day. The electric-car maker stock's beating was likely driven primarily by a tough day in the market for many stocks -- particularly for growth stocks like Tesla. The stock's downward trend has largely been tied to investors' skittishness toward highly valued growth stocks.
Cathie Wood is a long-time Tesla bull, but the stock isn't the largest holding in Wood's ARK Innovation ETF anymore.
What happened The ride in Ford (NYSE: F) stock wasn't very smooth on Friday. The big American carmaker saw its shares decline by nearly 3% on a day when the S&P 500 index essentially traded sideways. A ruling from a court overseas was the key catalyst in that deceleration.
In this article, we discuss 10 buy-the-dip stocks to buy according to billionaire Ken Fisher. If you want to skip our detailed analysis of Fisher’s stock selection and the current sell-off in tech, go directly to 5 Best Buy-the-Dip Tech Stocks According to Billionaire Ken Fisher. The tech-heavy Nasdaq Composite is down 27% in 2022 […]
Genco Shipping & Trading has been a port in the storm. A new dividend policy could more than keep the stock afloat.
The markets may be in free fall, but a few biotechnology companies had an exceptionally good day. Siga’s stock is up more than 40%; Emergent Biosolutions’s gained nearly 12%, and Tonix Pharmaceuticals, 15%. A few cases of monkeypox have been registered in Europe and North America, far from West and Central Africa where outbreaks typically emerge.
Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) are no longer big winners for investors. Let's first address the uncertainties for Moderna. There are questions about the high number of side effects of its experimental influenza vaccine.
An earnings recession is not the biggest threat facing the stock market right now. To show that an earnings recession doesn’t necessarily doom the stock market, consider the S&P 500’s (SPX) quarterly return when its earnings-per-share (EPS) is falling. On average over the past century, according to an analysis conducted by Ned Davis Research, the S&P 500 has performed better when its EPS were lower than a year previously — not higher.
The Dow Jones reversed higher while the S&P 500 battled out of bear market territory. Tesla stock dived amid reports about CEO Elon Musk.
High-yield dividend stocks have been viewed more favorably than high-multiple growth stocks these days. After yet another month of excessive market-wide selling, the yields of many top dividend stocks are slightly richer. As the Fed raises interest rates further, growth and value could continue to get slammed. This week, the Fed signaled that it's more than willing to keep the rate hikes coming until inflation backs down, even if it means jeopardizing a "soft landing" and inflicting more pain in
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett buys or sells shares of a company, Wall Street and investors tend to pay close attention. Since becoming CEO in 1965, he's overseen the creation of more than $680 billion in shareholder value and delivered an average annual return of 20.1% for Berkshire's Class A (BRK.A) shareholders (himself included).
The stock market’s recent weakness could be particularly hazardous to your wealth if you’re male, above the age of 45, married, have more dependents, or think you have excellent investment knowledge. Nearly a third of investors who “panic sell” swear off equities altogether, and never re-enter the market. This new study would be important to review at any time, but especially now, given the stock market’s recent losses.
Another week of big losses as Wall Street adjusts to a "hard" reality. Tesla broke decisively, but it wasn't alone.
These fast-growing stocks are ripe for the picking following a nearly 30% peak decline in the Nasdaq.